Shopping Cart
Remove All
Your shopping cart is currently empty
AT-0174 is an orally active dual inhibitor targeting IDO1 and TDO2 (tryptophan 2,3-dioxygenase-2), with IC50 values of 0.17 and 0.25 μM, respectively. It exhibits antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | AT-0174 is an orally active dual inhibitor targeting IDO1 and TDO2 (tryptophan 2,3-dioxygenase-2), with IC50 values of 0.17 and 0.25 μM, respectively. It exhibits antitumor activity. |
| Targets&IC50 | IDO1:0.17 μM |
| In vitro | AT-0174, administered at a dosage of 170 mg/kg/day orally for 15 consecutive days, can inhibit tumor growth in mice xenografted with non-small cell lung cancer. |
| Formula | C6H5ClFN3O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.